Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 3 hours 31 min ago
Verve Halts Trial for Lead Gene Editing Program Due to Safety Concerns
Verve Halts Trial for Lead Gene Editing Program Due to Safety Concerns 4/2/2024
Ipsen Inks Potential $900M Deal with Sutro for Global Rights to Preclinical ADC
Ipsen Inks Potential $900M Deal with Sutro for Global Rights to Preclinical ADC 4/2/2024
Vertex Pushes Oral Drug into Phase III Kidney Disease Trial, Eyes Accelerated Approval
Vertex Pushes Oral Drug into Phase III Kidney Disease Trial, Eyes Accelerated Approval 4/2/2024
Roivant Posts Phase II Eye Disease Win for TYK2 Drug, Plans Pivotal Program
Roivant Posts Phase II Eye Disease Win for TYK2 Drug, Plans Pivotal Program 4/2/2024
Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals Court Win
Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals Court Win 4/2/2024
Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year
Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year 4/2/2024
Gritstone Fails Cancer Vaccine Trial, Plans Phase III and Public Offering
Gritstone Fails Cancer Vaccine Trial, Plans Phase III and Public Offering 4/2/2024
World Pharma News
- Optimal timing maximises Paxlovid benefits for treating COVID-19
- European Commission approves Pfizer's EMBLAVEO® for patients with multidrug-resistant infections and limited treatment options
- Researchers develop a new way to safely boost immune cells to fight cancer
- How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
- Common HIV treatments may aid Alzheimer's disease patients